Search

Your search keyword '"Korobelnik, Jean-François"' showing total 632 results

Search Constraints

Start Over You searched for: Author "Korobelnik, Jean-François" Remove constraint Author: "Korobelnik, Jean-François"
632 results on '"Korobelnik, Jean-François"'

Search Results

3. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

5. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

7. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

9. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

11. Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus

12. The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus

13. Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration

15. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

17. DeepAlienorNet: A deep learning model to extract clinical features from colour fundus photography in age‐related macular degeneration.

18. Associations of drusen location with risk factors and incidence of late age‐related macular degeneration in the Alienor study.

19. Retinal microvasculature and risk of incident dementia over a 10‐year period: results from the 3C‐Alienor population‐based study

20. Faricimab Treat-and-Extend for Diabetic Macular Edema

27. Retinal microvasculature and incident dementia over 10 years: The Three‐City‐Alienor cohort

28. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

29. Ambient air pollution exposure and incidence of cataract surgery: the prospective 3City-Alienor study

30. Ophthalmologic Phenotype–Genotype Correlations in Patients With Oculocutaneous Albinism Followed in a Reference Center

38. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion

40. Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortium

41. Associations with intraocular pressure across Europe: The European Eye Epidemiology (E³) Consortium

42. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion

45. Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.

46. Diabetic retinopathy relates to the incidence of foot ulcers and amputations in type 2 diabetes

49. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome

Catalog

Books, media, physical & digital resources